Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Integrated differential transcriptome maps of Acute Megakaryoblastic Leukemia (AMKL) in children with or without Down Syndrome (DS).

Pelleri MC, Piovesan A, Caracausi M, Berardi AC, Vitale L, Strippoli P.

BMC Med Genomics. 2014 Dec 5;7:63. doi: 10.1186/s12920-014-0063-z.

2.

Chronic high levels of the RCAN1-1 protein may promote neurodegeneration and Alzheimer disease.

Ermak G, Davies KJ.

Free Radic Biol Med. 2013 Sep;62:47-51. doi: 10.1016/j.freeradbiomed.2013.01.016. Epub 2013 Jan 29. Review.

3.

Transcriptional regulation of miR-196b by ETS2 in gastric cancer cells.

Liao YL, Hu LY, Tsai KW, Wu CW, Chan WC, Li SC, Lai CH, Ho MR, Fang WL, Huang KH, Lin WC.

Carcinogenesis. 2012 Apr;33(4):760-9. doi: 10.1093/carcin/bgs023. Epub 2012 Jan 31.

4.

MicroRNAs: Meta-controllers of gene expression in synaptic activity emerge as genetic and diagnostic markers of human disease.

Ceman S, Saugstad J.

Pharmacol Ther. 2011 Apr;130(1):26-37. doi: 10.1016/j.pharmthera.2011.01.004. Epub 2011 Jan 20. Review.

5.

Effects of individual segmental trisomies of human chromosome 21 syntenic regions on hippocampal long-term potentiation and cognitive behaviors in mice.

Yu T, Liu C, Belichenko P, Clapcote SJ, Li S, Pao A, Kleschevnikov A, Bechard AR, Asrar S, Chen R, Fan N, Zhou Z, Jia Z, Chen C, Roder JC, Liu B, Baldini A, Mobley WC, Yu YE.

Brain Res. 2010 Dec 17;1366:162-71. doi: 10.1016/j.brainres.2010.09.107. Epub 2010 Oct 26.

6.

Molecular basis of pharmacotherapies for cognition in Down syndrome.

Gardiner KJ.

Trends Pharmacol Sci. 2010 Feb;31(2):66-73. doi: 10.1016/j.tips.2009.10.010. Epub 2009 Dec 4. Review.

Supplemental Content

Support Center